S-adenosylhomocysteine as a physiological modulator of Apo-1-mediated apoptosis
- PMID: 8757959
- DOI: 10.1093/intimm/8.7.1139
S-adenosylhomocysteine as a physiological modulator of Apo-1-mediated apoptosis
Abstract
APO-1/Fas (CD95) is a member of the tumor necrosis factor/nerve growth factor receptor superfamily and mediates apoptosis in various cell types. Here we show that L929 cells, expressing human APO-1 treated with agonistic antibodies (anti-APO-1), elicit an early and transient increase of S-adenosylhomocysteine (AdoHcy), a potent inhibitor of S-adenosylmethionine (AdoMet)-dependent methylation reactions. In contrast, anti-APO-1 did not induce an AdoHcy increase in L929-APO-1 Delta4 cells expressing a C-terminally truncated APO-1 lacking part of the 'death domain' known to be required for the transduction of apoptotic signals. Addition of adenosine and D, L-homocysteine also led to an increase of cellular AdoHcy thus enhancing anti-APO-1-induced killing of L929-APO-1 cells. Treatment with anti-APO-1 also induced release of arachidonic acid from phospholipids: this effect was augmented by elevated levels of AdoHcy. In contrast, AdoHcy had only a minor effect on anti-APO-1-mediated DNA fragmentation. These findings suggest that AdoHcy functions as a physiological modulator of APO-1-mediated cell death in L929 cells and enhances anti-APO-1-induced cell killing at least partially by acting via the phospholipase A2 pathway.
Similar articles
-
Effects of 4'-modified analogs of aristeromycin on the metabolism of S-adenosyl-L-homocysteine in murine L929 cells.Mol Pharmacol. 1993 Jun;43(6):989-97. Mol Pharmacol. 1993. PMID: 8316227
-
Effects of adenosine dialdehyde on S-adenosylhomocysteine hydrolase and S-adenosylmethionine-dependent transmethylations in mouse L929 cells.Mol Pharmacol. 1984 May;25(3):418-24. Mol Pharmacol. 1984. PMID: 6727864
-
Elucidation of the mechanism by which homocysteine potentiates the anti-vaccinia virus effects of the S-adenosylhomocysteine hydrolase inhibitor 9-(trans-2',trans-3'-dihydroxycyclopent-4'-enyl)-adenine.Mol Pharmacol. 1989 Sep;36(3):490-6. Mol Pharmacol. 1989. PMID: 2779528
-
On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.Leuk Lymphoma. 1998 Nov;31(5-6):477-90. doi: 10.3109/10428199809057607. Leuk Lymphoma. 1998. PMID: 9922038 Review.
-
Fas receptor (CD95)-mediated apoptosis in leukemic cells.Leuk Lymphoma. 1997 Mar;25(1-2):9-21. doi: 10.3109/10428199709042492. Leuk Lymphoma. 1997. PMID: 9130610 Review.
Cited by
-
Dietary supplementation with S-adenosyl methionine delays the onset of motor neuron pathology in a murine model of amyotrophic lateral sclerosis.Neuromolecular Med. 2010 Mar;12(1):86-97. doi: 10.1007/s12017-009-8089-7. Epub 2009 Sep 16. Neuromolecular Med. 2010. PMID: 19757209
-
Molecular ordering of the initial signaling events of CD95.Mol Cell Biol. 2002 Jan;22(1):207-20. doi: 10.1128/MCB.22.1.207-220.2002. Mol Cell Biol. 2002. PMID: 11739735 Free PMC article.
-
Autoimmune dysregulation and purine metabolism in adenosine deaminase deficiency.Front Immunol. 2012 Aug 27;3:265. doi: 10.3389/fimmu.2012.00265. eCollection 2012. Front Immunol. 2012. PMID: 22969765 Free PMC article.
-
Acute loss of renal function attenuates slow leukocyte rolling and transmigration by interfering with intracellular signaling.Kidney Int. 2011 Sep;80(5):493-503. doi: 10.1038/ki.2011.125. Epub 2011 May 11. Kidney Int. 2011. PMID: 21562471 Free PMC article.
-
Intracellular triggering of Fas aggregation and recruitment of apoptotic molecules into Fas-enriched rafts in selective tumor cell apoptosis.J Exp Med. 2004 Aug 2;200(3):353-65. doi: 10.1084/jem.20040213. J Exp Med. 2004. PMID: 15289504 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous